Brannan SK - Search Results

1

Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine.

Trivedi MH, Desaiah D, Ossanna MJ, Pritchett YL, Brannan SK, Detke MJ. Trivedi MH, et al. Among authors: brannan sk. Int Clin Psychopharmacol. 2008 May;23(3):161-9. doi: 10.1097/YIC.0b013e3282f41d7e. Int Clin Psychopharmacol. 2008. PMID: 18408530 Review.

2

Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies.

Brannan SK, Mallinckrodt CH, Detke MJ, Watkin JG, Tollefson GD. Brannan SK, et al. J Psychiatr Res. 2005 Mar;39(2):161-72. doi: 10.1016/j.jpsychires.2004.05.005. J Psychiatr Res. 2005. PMID: 15589564 Clinical Trial.

3

Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder.

Delgado PL, Brannan SK, Mallinckrodt CH, Tran PV, McNamara RK, Wang F, Watkin JG, Detke MJ. Delgado PL, et al. Among authors: brannan sk. J Clin Psychiatry. 2005 Jun;66(6):686-92. doi: 10.4088/jcp.v66n0603. J Clin Psychiatry. 2005. PMID: 15960560 Clinical Trial.

4

The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures.

Carmody TJ, Rush AJ, Bernstein I, Warden D, Brannan S, Burnham D, Woo A, Trivedi MH. Carmody TJ, et al. Eur Neuropsychopharmacol. 2006 Dec;16(8):601-11. doi: 10.1016/j.euroneuro.2006.04.008. Epub 2006 Jun 12. Eur Neuropsychopharmacol. 2006. PMID: 16769204 Free PMC article. Clinical Trial.

5

Making clinicians lives easier: guidance on use of the QIDS self-report in place of the MADRS.

Carmody TJ, Rush AJ, Bernstein IH, Brannan S, Husain MM, Trivedi MH. Carmody TJ, et al. J Affect Disord. 2006 Oct;95(1-3):115-8. doi: 10.1016/j.jad.2006.03.024. Epub 2006 May 16. J Affect Disord. 2006. PMID: 16707162 Free PMC article.

6

Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.

Brannan SK, Mallinckrodt CH, Brown EB, Wohlreich MM, Watkin JG, Schatzberg AF. Brannan SK, et al. J Psychiatr Res. 2005 Jan;39(1):43-53. doi: 10.1016/j.jpsychires.2004.04.011. J Psychiatr Res. 2005. PMID: 15504423 Clinical Trial.

7

Olanzapine treatment for post-traumatic stress disorder: an open-label study.

Petty F, Brannan S, Casada J, Davis LL, Gajewski V, Kramer GL, Stone RC, Teten AL, Worchel J, Young KA. Petty F, et al. Int Clin Psychopharmacol. 2001 Nov;16(6):331-7. doi: 10.1097/00004850-200111000-00003. Int Clin Psychopharmacol. 2001. PMID: 11712621 Clinical Trial.

8

Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study.

Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, Lavori P, Howland R, Kling MA, Rittberg B, Carpenter L, Ninan P, Moreno F, Schwartz T, Conway C, Burke M, Barry JJ. Rush AJ, et al. Among authors: brannan sk. Biol Psychiatry. 2005 Sep 1;58(5):355-63. doi: 10.1016/j.biopsych.2005.05.024. Biol Psychiatry. 2005. PMID: 16139581 Clinical Trial.

9

Sertraline and isocarboxazid cause a serotonin syndrome.

Brannan SK, Talley BJ, Bowden CL. Brannan SK, et al. J Clin Psychopharmacol. 1994 Apr;14(2):144-5. doi: 10.1097/00004714-199404000-00010. J Clin Psychopharmacol. 1994. PMID: 8195456 No abstract available.

10

Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.

Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, Howland R, Kling MA, Rittberg BR, Burke WJ, Rapaport MH, Zajecka J, Nierenberg AA, Husain MM, Ginsberg D, Cooke RG. Rush AJ, et al. Among authors: brannan sk. Biol Psychiatry. 2005 Sep 1;58(5):347-54. doi: 10.1016/j.biopsych.2005.05.025. Biol Psychiatry. 2005. PMID: 16139580 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page